bioRxivCancer Biology
Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer
B. Dong, J. Miao, Y. Wang, W. Luo, Z. Ji, H. Lai, M. Zhang, X. Cheng, J. Wang, Y. Fang, H. H. Zhu, C. W. Chua, L. Fan, Y. Zhu, J. Pan, J. Wang, W. Xue, W. Q. Gao
Abstract
Neuroendocrine prostate cancer is one of the most aggressive subtypes of prostate tumor. Although much progress has been made in understanding the development of neuroendocrine prostate cancer, the cellular architecture associated with neuroendocrine differentiation in human prostate cancer remain incompletely understood. Here, we use single-cell RNA sequencing to profile the transcriptomes of 21,292 cells from needle biopsies of 6 castration-resistant prostate cancers. Our analyses reveal that all neuroendocrine tumor cells display a luminal-like epithelial phenotype. In particular, lineage trajectory analysis suggests that focal neuroendocrine differentiation exclusively originate from luminal-like malignant cells rather than basal compartment. Further tissue microarray analysis validates the generality of the luminal phenotype of neuroendocrine cells. Moreover, we uncover neuroendocrine differentiation-associated gene signatures that may help us to further explore novel intrinsic molecular mechanisms deriving neuroendocrine prostate cancer. In summary, our single-cell study provides direct evidence into the cellular states underlying neuroendocrine transdifferentiation in human prostate cancer.
- organism: human
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Defining focal neuroendocrine differentiation as a transcriptionally distinct form of prostate cancer pathology characterized by the expression of androgen receptors
Rosalía Quezada Urban, Shivakumar Keerthikumar, … David L. Goode·Molecular OncologyPeer-reviewed·Jul 24, 2025
- Longitudinal single-cell RNA sequencing of a neuroendocrine transdifferentiation model reveals transcriptional reprogramming in treatment-induced neuroendocrine prostate cancer
Funda Sar, Hee Chul Chung, … Colin C. Collins·Genome MedicinePeer-reviewed·Oct 28, 2026
- Distinct neuroendocrine subtypes predict treatment-induced neuroendocrine prostate cancer prognosis and provide clues for personalized treatment
Yung-Chih Hong, Cheng‐Han Tsai, … Pei-Ching Chang·bioRxiv·Sep 28, 2024
- Longitudinal single-cell profiling links RUNX1T1 to lineage transition and maintenance in treatment-induced neuroendocrine prostate cancer
Yuchao Ni, Mingchen Shi, … Yuzhuo Z. Wang·bioRxiv·May 14, 2025
- Multilineage plasticity in prostate cancer through expansion of stem-like luminal epithelial cells with elevated inflammatory signaling
S. Zaidi, J. L. Zhao, … C. L. Sawyers·bioRxiv·Nov 1, 2021
- Deciphering the Transcription Factor Landscape in Neuroendocrine Prostate Cancer Progression: A Novel Approach to Understand NE Transdifferentiation
Yu Wang, Hui Xue, … Yuzhuo Z. Wang·Advanced SciencePeer-reviewed·Mar 17, 2025